Pacira BioSciences Q2 2022 Earnings Preview

• Pacira BioSciences (NASDAQ:PCRX) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open.
• The consensus EPS Estimate is $0.85 (+10.4% Y/Y) and the consensus Revenue Estimate is $169.27M (+24.8% Y/Y).
• Over the last 2 years, PCRX has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
• Over the last 3 months, EPS estimates have seen 2 upward revisions and 6 downward. Revenue estimates have seen 0 upward revisions and 5 downward.